CpG DNA as a vaccine adjuvant

C Bode, G Zhao, F Steinhagen, T Kinjo… - Expert review of …, 2011 - Taylor & Francis
Synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs trigger cells
that express Toll-like receptor 9 (including human plasmacytoid dendritic cells and B cells) …

Nucleic acid immunity

G Hartmann - Advances in immunology, 2017 - Elsevier
Organisms throughout biology need to maintain the integrity of their genome. From bacteria
to vertebrates, life has established sophisticated mechanisms to detect and eliminate foreign …

TLR-based immune adjuvants

F Steinhagen, T Kinjo, C Bode, DM Klinman - Vaccine, 2011 - Elsevier
This work describes the nature and strength of the immune response induced by various Toll-
like receptor ligands and their ability to act as vaccine adjuvants. It reviews the various …

Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7

V Hornung, M Guenthner-Biller, C Bourquin… - Nature medicine, 2005 - nature.com
Short interfering RNA (siRNA) is used in RNA interference technology to avoid non-target-
related induction of type I interferon (IFN) typical for long double-stranded RNA. Here we …

The grateful dead: damage‐associated molecular pattern molecules and reduction/oxidation regulate immunity

MT Lotze, HJ Zeh, A Rubartelli… - Immunological …, 2007 - Wiley Online Library
The response to pathogens and damage in plants and animals involves a series of carefully
orchestrated, highly evolved, molecular mechanisms resulting in pathogen resistance and …

Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose

A De Titta, M Ballester, Z Julier… - Proceedings of the …, 2013 - National Acad Sciences
In subunit vaccines, strong CD8+ T-cell responses are desired, yet they are elusive at
reasonable adjuvant doses. We show that targeting adjuvant to the lymph node (LN) via …

Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history

P Fitzgerald-Bocarsly, J Dai, S Singh - Cytokine & growth factor reviews, 2008 - Elsevier
It has been 50 years since the initial descriptions of what are now known as plasmacytoid
dendritic cells (pDC) and type I IFN. pDC, which are infrequent cells found in the peripheral …

Development of TLR9 agonists for cancer therapy

AM Krieg - The Journal of clinical investigation, 2007 - Am Soc Clin Investig
In vertebrates, the TLRs are a family of specialized immune receptors that induce protective
immune responses when they detect highly conserved pathogen-expressed molecules …

CpG oligonucleotides as vaccine adjuvants

N Kayraklioglu, B Horuluoglu, DM Klinman - DNA Vaccines: Methods and …, 2021 - Springer
CpG Oligonucleotides (ODN) are immunomodulatory synthetic oligonucleotides specifically
designed to stimulate Toll-like receptor 9. TLR9 is expressed on human plasmacytoid …

The immunobiology of the TLR9 subfamily

H Wagner - Trends in immunology, 2004 - cell.com
Members of the Toll-like receptor 9 (TLR9) subfamily are evolutionarily related and sense
viral and bacterial infections at the endosomal subcellular compartment. Whereas TLR9 …